| scholarly article | Q13442814 |
| P50 | author | Luc Buée | Q56526742 |
| Patrick Dutar | Q57455822 | ||
| David Blum | Q40181632 | ||
| P2093 | author name string | Raphaëlle Caillierez | |
| Sandrine Humez | |||
| Emilie Faivre | |||
| Dominique Demeyer | |||
| Charlotte Laloux | |||
| Claire Alves Pires | |||
| Elodie Marciniak | |||
| P2860 | cites work | Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy | Q57566967 |
| Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases | Q81396931 | ||
| CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity | Q21129473 | ||
| CCL3 correlates with the number of mood disturbances and personality changes in patients with Alzheimer's disease | Q24300040 | ||
| Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity | Q24650569 | ||
| Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors | Q26995483 | ||
| Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences | Q27023841 | ||
| Synaptic plasticity: multiple forms, functions, and mechanisms | Q28242702 | ||
| Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage | Q28576511 | ||
| Learning induces long-term potentiation in the hippocampus | Q29619482 | ||
| The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche | Q30460340 | ||
| The CC chemokine receptor 5 regulates olfactory and social recognition in mice. | Q30460369 | ||
| Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice | Q30477209 | ||
| Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide | Q30490518 | ||
| Contextual learning requires synaptic AMPA receptor delivery in the hippocampus | Q30502955 | ||
| CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. | Q31920342 | ||
| Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain | Q34074221 | ||
| Long-term depression in the CNS. | Q34121481 | ||
| Glial biology in learning and cognition | Q34167504 | ||
| Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. | Q34277092 | ||
| Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures. | Q34348557 | ||
| Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats | Q35014514 | ||
| TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease | Q35203740 | ||
| CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120 | Q35207533 | ||
| Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes | Q35795750 | ||
| Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. | Q36187095 | ||
| Chemokines and brain functions | Q36230513 | ||
| Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity | Q36752538 | ||
| Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory | Q37438023 | ||
| Chemokines and their receptors: orchestrating a fine balance between health and disease | Q37603336 | ||
| GLIA modulates synaptic transmission. | Q37629216 | ||
| Chemokine receptors intracellular trafficking. | Q37745630 | ||
| Chemokines and chemokine receptors: new actors in neuroendocrine regulations. | Q37771976 | ||
| Immune modulation of learning, memory, neural plasticity and neurogenesis | Q37802555 | ||
| Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. | Q37896669 | ||
| Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability | Q38078697 | ||
| Current status of chemokines in the adult CNS. | Q38085956 | ||
| Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β. | Q38246435 | ||
| Astrocytes: Orchestrating synaptic plasticity? | Q38415648 | ||
| A2A adenosine receptor deletion is protective in a mouse model of Tauopathy | Q41755392 | ||
| Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats | Q41807236 | ||
| Anti-inflammatory impact of minocycline in a mouse model of tauopathy. | Q41854166 | ||
| APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. | Q41893910 | ||
| Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices | Q42159792 | ||
| Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. | Q42280027 | ||
| Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. | Q42490806 | ||
| Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains | Q42851040 | ||
| LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). | Q43285433 | ||
| Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain | Q43831369 | ||
| CCR3, CCR2A and macrophage inflammatory protein (MIP)-1a, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE) . | Q45985831 | ||
| Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. | Q45992275 | ||
| CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. | Q46036847 | ||
| RANTES modulates the release of glutamate in human neocortex | Q46237602 | ||
| Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease | Q46787216 | ||
| Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. | Q47305370 | ||
| Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population. | Q47943288 | ||
| The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro | Q48147811 | ||
| Prolonged increase in rat hippocampal chemokine signalling after status epilepticus | Q48649560 | ||
| Characterization of the expression of macrophage inflammatory protein-1α (MIP-1α) and C-C chemokine receptor 5 (CCR5) after kainic acid-induced status epilepticus (SE) in juvenile rats | Q48711732 | ||
| Status epilepticus evokes prolonged increase in the expression of CCL3 and CCL4 mRNA and protein in the rat brain. | Q49087699 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15862 | |
| P577 | publication date | 2015-10-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory | |
| P478 | volume | 5 |
| Q37432334 | (Putative) sex differences in neuroimmune modulation of memory. |
| Q57896338 | Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease |
| Q37565466 | Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation. |
| Q57112440 | CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons |
| Q92830489 | CD22 blockade restores homeostatic microglial phagocytosis in ageing brains |
| Q56449335 | Characterization of the immune response following in vitro mayaro and chikungunya viruses (Alphavirus, Togaviridae) infection of mononuclear cells |
| Q92970138 | Chemokines in Alzheimer's Disease: New Insights Into Prokineticins, Chemokine-Like Proteins |
| Q47709549 | Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis |
| Q52315330 | Complex role of chemokine mediators in animal models of Alzheimer's Disease. |
| Q102053756 | Delirium |
| Q90117079 | Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain |
| Q47550160 | Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection. |
| Q33605737 | Gene expression patterns associated with neurological disease in human HIV infection |
| Q39210948 | Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy |
| Q52316042 | Innate Immune Signaling and Alcohol Use Disorders. |
| Q55380454 | Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice. |
| Q89207621 | New role of P2X7 receptor in an Alzheimer's disease mouse model |
| Q50198442 | Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake. |
| Q47860695 | Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy |
| Q42656164 | SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy |
| Q48419551 | Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease |
| Q52315334 | Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? |
Search more.